Next-generation sequencing identifies thousands of cancer patients who cannot receive immunotherapy
Brigham researchers’ next-generation sequencing findings suggest that updating current cancer treatment guidelines could allow approximately 6,000 more patients in the United States to benefit from immunotherapy treatment each year. suggests Immunotherapy is a highly effective treatment for patients whose cancer has mismatch repair defects, and new research identifies more cancer patients who could benefit from […]